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icrotubules (MTs) polymerized with GMPCPP, a
slowly hydrolyzable GTP analogue, are stable in
buffer but are rapidly depolymerized in 
 
Xenopus
 
egg extracts. This depolymerization is independent of three
previously identiﬁed MT destabilizers (Op18, katanin, and
XKCM1/KinI). We puriﬁed the factor responsible for this
novel depolymerizing activity using biochemical fractionation
and a visual activity assay and identiﬁed it as XMAP215,
previously identiﬁed as a prominent MT growth–promoting
protein in 
 
Xenopus
 
 extracts. Consistent with the puriﬁcation
results, we ﬁnd that XMAP215 is necessary for GMPCPP-MT
M
 
destabilization in extracts and that recombinant full-length
 
XMAP215 as well as an NH
 
2
 
-terminal fragment have depoly-
merizing activity in vitro. Stimulation of depolymerization
 
is speciﬁc for the MT plus end. These results provide evidence
for a robust MT-destabilizing activity intrinsic to this micro-
tubule-associated protein and suggest that destabilization
may be part of its essential biochemical functions. We
propose that the substrate in our assay, GMPCPP-stabilized
MTs, serves as a model for the pause state of MT ends and
that the multiple activities of XMAP215 are uniﬁed by a
mechanism of antagonizing MT pauses.
 
Introduction
 
Microtubule (MT)* polymerization dynamics have been
implicated in many important cellular events, including cell
polarization, motility, and division. They are regulated by
cellular factors that both stabilize and destabilize the MT
lattice. During mitosis, for example, increased MT dynamicity
allows more efficient search and capture of kinetochores by
MT ends (Holy and Leibler, 1994). This increased dynamicity
is driven by increases in catastrophe rate in some systems
(Belmont et al., 1990) and/or decreases in rescue rate in others
(Gliksman et al., 1992; Rusan et al., 2001). A number of MT
dynamics regulators have been identified and characterized
in recent years, and investigators in the field are actively
pursuing the assignment of specific regulators to specific
cellular events.
Three important MT destabilizers have been characterized
in meiotic 
 
Xenopus
 
 egg extract: katanin (McNally and Vale,
1993), Op18/stathmin (Belmont and Mitchison, 1996), and
XKCM1/MCAK (a member of the KinI family of kinesins)
(Walczak et al., 1996). Of these three, the KinI family members
appear to be the most important negative regulators of MT
polymerization during mitosis (Belmont and Mitchison,
1996; Maney et al., 2001; Kline-Smith and Walczak, 2002).
We set out to determine if there were any other MT destabi-
lizers in 
 
Xenopus
 
 egg extract, using GMPCPP-stabilized
MTs (CPP MTs) as the substrate in our depolymerization
assays. CPP MTs were used in part for practical reasons
(they are stable to dilution in buffer) and in part because
they provide a novel assay that might identify factors with
new mechanisms of action.
CPP MTs are stable to dilution because the nucleotide is
only slowly hydrolyzed and thus mimics the GTP- or
GDP-Pi–bound state (Hyman et al., 1992). However, we
do not know precisely what state of physiological MTs
they most closely resemble. They have been hypothesized
to mimic the GTP cap, a hypothetical structure stabilizing
the ends of actively growing MTs (Drechsel and Kirschner,
1994; Caplow and Shanks, 1996). In this paper, we suggest
an alternative possibility, that CPP MTs most closely
mimic a hypothetical “paused” state of the MT lattice, an
intermediate between the growing and shrinking states
(Tran et al., 1997).
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Results
 
Meiotic 
 
Xenopus
 
 egg extracts contain a novel 
MT-depolymerizing factor
 
To assay for MT-depolymerizing factors, we added rho-
damine-labeled CPP MTs to crude or clarified cytostatic
factor (CSF)–arrested 
 
Xenopus
 
 egg extract (CSF extract) and
observed their disappearance over time. CPP MTs are stable
to dilution in buffer, but when added to extract, they depo-
lymerize in 5–10 min (Caplow, M., personal communica-
tion). To characterize this depolymerizing activity, we sedi-
mented clarified CSF extract on a 5–20% sucrose gradient
and assayed fractions for depolymerizing activity. A single
ATP-independent peak of activity was observed at 
 
 
 
9.5S
(Fig. 1 B). XKCM1 cosedimented with this peak (Fig. 1 A),
but katanin and Op18 did not (unpublished data). The ac-
tivity appeared to be independent of XKCM1 because
XKCM1 requires ATP for efficient MT depolymerization
(Desai et al., 1999b). To confirm that XKCM1 was not re-
sponsible for the depolymerizing activity, we assayed those
fractions in the absence of ATP and in the presence of inhib-
itory 
 
 
 
-XKCM1 antibody (Walczak et al., 1996) (Fig. 1 B).
Depolymerizing activity was not blocked, suggesting that
another factor was responsible.
 
Identification of the depolymerizing activity as a 
fragment of XMAP215
 
We purified the unknown CPP MT–depolymerizing factor
using conventional chromatography. The assay consisted of
adding rhodamine-labeled CPP MTs to each fraction and
fixing at time points to observe the disappearance of these
MTs by fluorescence microscopy. Relative activity of each
fraction was estimated by serial dilution. The key strategic
issue was separation of the novel CPP MT–depolymerizing
activity from other activities that either inhibited the assay
(bundling factors) or scored in the assay (known destabiliz-
ers). To avoid confusion between the novel activity and
XKCM1, we purified the novel activity from a 40% ammo-
nium sulfate (AS) supernatant of clarified CSF extract,
which contained only a fraction of total depolymerizing ac-
tivity, but was free of the known depolymerizers, XKCM1,
katanin, and Op18, by Western blot (unpublished data).
The CPP MT–depolymerizing factor was purified using
seven steps: AS precipitation, phenyl sepharose, heparin,
monoS, gel filtration, monoQ (pH 7.2), and a final monoS
column. When fractions were separated by SDS-PAGE and
silver stained, a set of polypeptides of 
 
 
 
130 kD and a pro-
tein of 
 
 
 
160 kD consistently coeluted with activity on the
last two columns in the purification (Fig. 2, A and B, ar-
rows). We estimated that specific activity was enriched sev-
eral thousand fold by the final monoS step (Table I).
Attempts at further purification resulted in extensive loss
of activity and protein. Instead, two independent purifica-
Figure 1. There is a CPP MT–depolymerizing activity in Xenopus 
egg extract independent of XKCM1. (A) XKCM1 overlaps with the 
peak of depolymerizing activity on sucrose gradients. 50  l of clarified 
CSF extract was sedimented over a 5–20% sucrose gradient. Western 
blot of fractions showed that XKCM1 is present in fractions 10–18. 
CPP MT–depolymerizing activity peaked in fractions 9–14 (see B). 
Arrows below the blot indicate sedimentation values for protein 
standards run on a parallel gradient. Active fractions are labeled 
with asterisks. (B) Inhibition of XKCM1 did not inhibit depolymerizing 
activity in sucrose gradient fractions. Fractions from the sucrose 
gradient shown in A were assayed for depolymerizing activity, using 
rhodamine-labeled CPP MTs as described in the Materials and 
methods. Each fraction was assayed in the absence of ATP and in 
the presence of random IgG or inhibitory amounts of  -XKCM1 anti-
body and fixed after 10 min. XKCM1 depolymerizing activity is ATP 
dependent. As shown, neither the absence of ATP nor the presence 
of  XKCM1 antibody blocked the depolymerizing activity of active 
fractions. Active fractions are labeled with asterisks. Bar, 10  m.
 
Table I. 
 
Purification of CCP MT–depolymerizing activity from 
 
Xenopus
 
 egg extract
Step Total activity Protein Specific activity Fold purification
 
U
 
 
 
gU /
 
 
 
g
 
HSS 440,000 1,320,000 0.33 1.00
AS supe 400,000 524,000 0.76 2.30
Phenyl sepharose 300,000 122,000 2.45 7.40
Heparin 150,000 2,410 62.30 188.79
MonoS 1 72,000 595 121.00 366.67
Superose 6 15,000 65 230.77 699.30
MonoQ FT 10,000 28 357.14 1,082.24
MonoS 2 4,500 5 900.00 2,727.27
Activity was defined as the maximal dilution that would depolymerize all microtubules in the visual assay within 10 min (see Materials and methods). HSS,
high-speed supernatant; AS supe, 40% AS supernatant.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
XMAP215 is a microtubule destabilizer |
 
 Shirasu-Hiza et al. 351
 
tion steps (sucrose gradient and monoQ, pH 8.8) were per-
formed in parallel with the above purification, starting with
active fractions from the gel filtration step. In both of these
steps, the same set of 130- and 160-kD proteins continued
to peak in active fractions (unpublished data).
The cluster of polypeptides at 130 kD were excised from
an 8% polyacrylamide gel and identified by liquid chroma-
tography tandem mass spectrometry. 21 peptides from the
tryptic digest matched the sequence of XMAP215, a previ-
ously identified 215-kD 
 
Xenopus
 
 MT-binding protein (Gard
and Kirschner, 1987). Each of these peptides mapped to the
NH
 
2
 
-terminal half of the sequence, suggesting that we had
purified an NH
 
2
 
-terminal fragment of XMAP215 (unpub-
lished data). Western blots using antibodies specific to the
NH
 
2
 
 and COOH termini of XMAP215 (Fig. 2 C) con-
firmed that the set of p130 bands as well as the p160 band
enriched in our purification were NH
 
2
 
-terminal fragments
of XMAP215.
 
XMAP215 is a major CPP MT–depolymerizing factor in 
 
Xenopus
 
 egg extract
 
We next investigated whether XMAP215 constituted a CPP
MT–depolymerizing factor in CSF extracts. Though we had
purified a set of NH
 
2
 
-terminal XMAP215 fragments from
crude extract, we could not detect those fragments by West-
ern blot in crude or clarified extract. XMAP215 appeared to
exist as a full-length 215-kD species. This full-length
XMAP215 comigrated with the 9.5S peak of depolymeriz-
ing activity we originally observed during sucrose gradient
Figure 2. Proteins of 130 and 160 kD were enriched during the 
purification and consistently copeaked with activity. (A) Specific 
activity increased with each step of the purification, as did the 
prominence of p160 and p130 bands (arrows). Shown here is a 
silver-stained polyacrylamide gel containing fractions from the 
purification. Samples for the first seven lanes are listed as follows: 
mw, molecular weight markers; AS supe, 40% AS supernatant 
(5  g protein; 4 U of specific activity); PS pool, phenyl sepharose 
pool of active fractions (4  g; 10 U); hep pool, heparin pool (4.8  g; 
300 U); monoS 1, first monoS column (5  g; 600 U); sup6, gel 
filtration/superose 6 (2.5  g; 600 U). The remaining lanes (monoS2) 
represent fractions from the second monoS column; depolymerizing 
activity peaked in fractions 16, 17, and 18 (see B). Lanes loaded 
with these fractions each contain  1.3  g of total protein and 1,260 U 
of specific activity. Arrows indicate p130 and p160 bands. Identity of 
the p130 bands (lower arrows) from these fractions was determined 
by mass spectrometry. (B) Activity profile for fractions for the monoS2 
step. Relative activity was estimated for fractions 8–24 by serial titration 
in the depolymerization assay and is presented in this graph as 
arbitrary units per microgram protein. (C) p160 and p130 bands are 
NH2-terminal fragments of XMAP215. Western blots of high-speed 
supernatant (hss) and monoS2 fractions were probed for XMAP215 
with NH2-terminal– or COOH-terminal–specific antibodies.
Figure 3. XMAP215 contributes to CPP MT–depolymerizing activity 
in CSF extract. (A) Full-length XMAP215 copeaks with depolymerizing 
activity on a sucrose gradient. Sucrose gradient fractions were 
analyzed by Western blot with COOH-terminal–specific  -XMAP215 
antibody. Active fractions are labeled with asterisks. (B) Crude extract 
was specifically depleted of full-length XMAP215, XKCM1, or both. 
Samples were depleted with random IgG, COOH-terminal  -XMAP215 
antibody ( XMAP215),  -XKCM1 antibody ( XKCM1), or both 
 -XMAP215 and  -XKCM1 antibodies ( both). Western blots for 
the four major depolymerizers (XMAP215, XKCM1, katanin, and 
Op18) are shown for each condition. (C) Depletion of XMAP215 
and XKCM1 from crude extract inhibited CPP MT depolymerization. 
Rhodamine-labeled CPP MTs were incubated in depleted extracts 
for 10 min. Representative fluorescence images of each sample are 
shown. Buffer used for negative control was CSF-XB (extract buffer 
used, see Materials and methods). Bar, 10  m.T
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sedimentation of clarified extract (Fig. 3 A). It is not clear if
we purified a rare, truncated species of XMAP215 that is
highly active in our assay or if endogenous full-length pro-
tein was proteolyzed during the purification. The latter ex-
planation seems likely as our depolymerizing factor de-
creased in sedimentation value from 9.5 to 6S (unpublished
data) during the purification and as XMAP215 is known to
be labile to a variety of nonspecific proteases in vitro (Gard,
D., personal communication).
To test if removal of this full-length XMAP215 would de-
crease CPP MT–destabilizing activity, crude extracts were
immunodepleted of XMAP215 using a COOH-terminal
antibody. Unfortunately, NH
 
2
 
-terminal antibodies were not
able to deplete efficiently, and NH
 
2
 
-terminal fragments, if
they were present, remained in the extracts. We also per-
formed immunodepletion of XKCM1 and double depletion
of both XMAP215 and XKCM1. Western blots of the de-
pleted extracts demonstrated 
 
 
 
95% depletion of each pro-
tein (Fig. 3 B). Levels of nondepleted protein (XKCM1 or
XMAP215), as well as katanin and Op18, were unchanged
in depleted extracts relative to mock-depleted extracts (Fig. 3
B). Nocodazole, a small molecule that sequesters tubulin
dimer, was added to each assay to prevent endogenous tubu-
lin from polymerizing onto the ends of the CPP MTs,
as MT elongation would complicate the analysis of desta-
bilization. Depleted extracts had spindle phenotypes sim-
ilar to those previously published (Walczak et al., 1996;
Tournebize et al., 2000; see Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200211095/DC1).
When rhodamine-labeled CPP MTs were added to mock-
depleted extracts, there was a large decrease in the total
amount of polymer within 5 min (Fig. 3 C). In extract de-
pleted of XMAP215, CPP MT depolymerization was par-
tially inhibited. This inhibition was roughly similar to
XKCM1 depletion and was partially restored by addition of
recombinant full-length protein (unpublished data). Fur-
thermore, depletion of both XKCM1 and XMAP215 led to
 
less total depolymerizing activity than single depletion of ei-
ther alone. In the experiment shown here, for example, at
the 5-min time point, 
 
 
 
XKCM1 extract had 21 times more
polymer than mock-depleted extract, 
 
 
 
XMAP215 had 23
times more polymer, and double-depleted extract had 37-
fold more MT polymer. Evidently both proteins contribute
significantly to the total CPP MT–depolymerizing activity
of crude extract. MT polymer was determined by total fluo-
rescent pixel area above background, a measurement that re-
flects both MT number and MT length.
 
XMAP215 depolymerizes CPP MTs in vitro
 
We next assayed pure, baculovirus-expressed XMAP215 for
CPP MT–depolymerizing activity in vitro, using both full-
length and truncated XMAP215 constructs previously char-
acterized by Popov et al. (2001; see Fig. S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200211095/DC1). Both
full-length protein and an NH
 
2
 
-terminal fragment (aa
1–560) were able to depolymerize rhodamine-labeled CPP
MTs in vitro (Fig. 4 A). In serial titrations, activity for both
polypeptides was similar and measurable, beginning between
6.25 and 12.5 nM (Fig. 4 B). The full-length protein sample
does contain a small amount of cleaved protein, so we can-
not definitively rule out that this is not the active species in
our assay; however, the majority of the protein is full-length.
The NH
 
2
 
-terminal fragment does not appear to be signifi-
cantly more potent than the full-length protein. A COOH-
terminal fragment of XMAP215 (aa 1168–2065), on the
other hand, was completely inactive in the depolymerization
assay (Fig. 4, A and B). We measured depolymerizing activ-
ity in the visual assay by using fluorescent pixel area per vi-
sual field to quantitate MT polymer. Sedimentation assays
and quantitation of tubulin in supernatants and pellets gave
similar results (unpublished data). Samples with high con-
centrations of full-length XMAP215 (stoichiometric with tu-
bulin, 
 
 
 
200 nM) showed less depolymerization and highly
bundled MTs (Fig. 4 A). This was also seen, to a lesser ex-
Figure 4. Pure recombinant XMAP215 
depolymerizes CPP MTs in vitro. 
(A) Full-length XMAP215 and an NH2-
terminal fragment of XMAP215 both 
depolymerize CPP MTs, but a COOH-
terminal fragment does not. Rhodamine-
labeled CPP MTs were incubated for 
15 min in buffer containing different 
concentrations of full-length XMAP215 
(F), an NH2-terminal fragment (N), or a 
COOH-terminal fragment (C). Shown 
here are representative fluorescence 
images for four concentrations of each 
protein. Bar, 10  m. (B) Full-length 
XMAP215 and the NH2-terminal fragment 
have depolymerizing activity between 
6.25 and 200 nM. MT polymer was 
quantitated for each sample by calculating 
average fluorescent pixel area per field 
for each protein concentration of full-
length (F), NH2-terminal (N), and COOH-
terminal (C) XMAP215. MT polymer is 
expressed as percent median value of buffer control; error bars denote 10th and 90th percentile; the 75th, 50th, and 25th percentiles are 
represented by the top, middle, and bottom of each box.T
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tent, in samples with very high concentrations of NH
 
2
 
-ter-
minal fragment (unpublished data). The COOH-terminal
fragment did not cause bundling at any concentration.
It is not surprising that we do not normally see the poly-
merization-promoting activity of XMAP215 in our assay,
even at concentrations similar to previously published re-
ports. Our assay differs from dynamic MT assays in several
ways that strongly select for depolymerizing activity: the as-
say is performed at room temperature, uses CSF-XB instead
of BRB80 buffer, and contains little or no soluble tubulin
dimer for polymerization. The same full-length XMAP215
construct used in our depolymerization assays was shown to
have polymerization-promoting activity in dynamic MT as-
says (Kinoshita et al., 2001).
 
XMAP215-promoted depolymerization is specific 
to MT plus ends
 
To test if XMAP215 promotes CPP MT depolymerization
by an end-dependent mechanism, we recorded depolymer-
ization live in glass flow-cells using time-lapse fluorescence
 
microscopy. Rhodamine-labeled CPP MTs were bound to
glass using kinesin and then treated with buffer or buffer
containing XMAP215. In buffer alone, MTs were relatively
stable for 30 min; in the presence of 19 nM XMAP215, they
depolymerized over several minutes in an endwise fashion
(Fig. 5 A). There was a strong polarity bias to depolymeriza-
tion. We used dim-bright CPP MTs and kinesin motility to
determine that XMAP215 depolymerized the MT plus end
at a rate 5–10 times faster than buffer alone, whereas minus
end depolymerization was not measurably affected (Fig. 5
B). In the presence of XMAP215, 92 out of 95 MTs
(96.8%) had faster rates of depolymerization on their lag-
ging (plus) ends than on their leading (minus) ends. Thus,
XMAP215 specifically promotes CPP MT depolymerization
at plus ends (see Video 1, available at http://www.jcb.org/
cgi/content/full/jcb.200211095/DC1). Its polymerization-
promoting activity is also plus end specific (Gard and Kirsch-
ner, 1987; Vasquez et al., 1994).
 
Mechanism of CPP MT depolymerization by XMAP215
 
There are several mechanisms by which XMAP215 might
accelerate CPP MT depolymerization. XMAP215 might
sequester GMPCPP-tubulin dimers, increase the rate of
GMPCPP hydrolysis, or increase the dissociation rate by
disrupting the lattice. We ruled out the trivial possibility
that our XMAP215 protein preparation contained pro-
teolytic activity by performing SDS-PAGE of depolymeriza-
tion products (unpublished data).
To test if dimer sequestration accelerates apparent CPP
MT depolymerization (by inhibiting readdition of subunits
to MT ends), we added nocodazole to CPP MTs diluted in
buffer alone (Fig. 6 A). The same concentration of nocoda-
zole added before CPP MT polymerization completely in-
hibited polymerization (unpublished data). However, this
potent monomer-sequestering drug did not stimulate depo-
lymerization of CPP MTs in our assay, presumably because
the total tubulin concentration is too low to allow signifi-
cant readdition of dimer to MT ends. To test if GMPCPP
was hydrolyzed during XMAP215-promoted depolymeriza-
tion, we used MTs polymerized with [
 
 
 
-
 
32
 
P]GMPCPP and
separated from unbound nucleotides by sedimentation
through a sucrose cushion. No hydrolysis was observed in
buffer or XMAP215, though Na-BRB80/60% glycerol (a
positive control; Caplow et al., 1994) did stimulate hydroly-
sis (Fig. 6 B).
To test if XMAP215 disrupted protofilament interac-
tions within the MT lattice, we imaged CPP MTs before
and during treatment with either full-length or NH
 
2
 
-termi-
nal XMAP215 by negative-stain electron microscopy. In
buffer alone, CPP MT ends were blunt (Fig. 6 C). In the
presence of XMAP215 (full length or NH
 
2
 
-terminal frag-
ment), we consistently observed bulbs of material at the
ends of the depolymerizing MTs. In some images, these
bulbs appeared to contain curled up protofilaments. We
cannot state definitively if these structures contain tubulin,
XMAP215, or both; however, they are reminiscent of those
resulting from treatment with KinI kinesins (Desai et al.,
1999b). We favor a similar unpeeling mechanism for CPP
MT depolymerization by XMAP215, though KinI and
XMAP215 do differ mechanistically in two interesting
Figure 5. XMAP215 promotes CPP MT depolymerization at MT 
plus ends. (A) XMAP215 promotes end-dependent CPP MT depoly-
merization. Shown here are images from a time-lapse series of 
dim-bright CPP MTs (see Materials and methods) treated with buffer 
alone or buffer plus 19 nM XMAP215 (interval between still images 
is 40 s). In each sample, kinesin motility was used to determine MT 
polarity; translocation of the MT from left to right represents minus 
end leading and plus end lagging. In the XMAP215-treated sample, 
the plus end shortens while the minus end remains stable (see Video 
1, available at http://www.jcb.org/cgi/content/full/jcb.200211095/
DC1). (B) Depolymerization by XMAP215 is specific to MT plus 
ends. Depolymerization rates were quantitated for each MT end 
from experiments as in A. Error bars denote 10th and 90th percentile; 
75th, 50th, and 25th percentiles are represented by the top, middle, 
and bottom of each box.T
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ways. First, KinI requires ATP hydrolysis to depolymerize
CPP MTs efficiently, and XMAP215 does not. Second, un-
like KinI, XMAP215 did not depolymerize taxol-stabilized
GDP MTs (unpublished data).
 
Discussion
 
XMAP215 is a major CPP MT–depolymerizing factor 
in 
 
Xenopus
 
 egg extract
 
MT dynamics are subject to regulation by both stabilizing
and destabilizing factors in vivo. Our overall goal in this
project was to identify and characterize novel destabilizers.
Although three such factors were already known in 
 
Xenopus
 
egg extracts (Op18/stathmin, XKCM/KinI, and katanin),
our initial experiments with CPP MTs suggested that these
factors could not account for all destabilizing activity. We
set out to isolate the novel factor(s) using biochemical frac-
tionation and purified a fragment of XMAP215. We subse-
quently showed that XMAP215 is a major CPP MT–depo-
lymerizing factor in 
 
Xenopus
 
 egg extract and that low
concentrations of pure recombinant XMAP215 promote de-
polymerization of CPP MTs in vitro. XMAP215 had not
previously been tested for its ability to depolymerize CPP
MTs, an artificial MT substrate. We believe that this in vitro
activity could have important mechanistic implications for
both the molecular mechanism of XMAP215 and, more
broadly, the mechanism of dynamic instability. Before dis-
cussing those mechanistic implications, we will first briefly
discuss the physiological significance of our results.
Finding that XMAP215 is a major MT-destabilizing fac-
tor is at odds with the current view of this protein as an im-
portant MT growth–promoting factor. It was first discov-
ered more than 10 yr ago by Gard and Kirschner (1987),
through biochemical fractionation and a visual assay for MT
polymerization, almost the converse of our depolymeriza-
tion assay. Homologues exist in almost every organism, in-
cluding 
 
Saccharomyces
 
 
 
cerevisiae
 
 (stu2), 
 
Schizosaccharomyces
pombe
 
 (dis1, alp14), 
 
Caenorhabditis
 
 
 
elegans
 
 (zyg-9), 
 
Dro-
sophila
 
 
 
melanogaster
 
 (msps), 
 
Arabidopsis
 
 (mor1), and humans
(ch-TOG) (for review see Ohkura et al., 2001). The two
most common phenotypes for decreased levels of this pro-
tein family are short MTs and defects in spindle pole forma-
tion. In vitro, pure XMAP215 is known to promote poly-
merization specifically on the MT plus end (Gard and
Kirschner, 1987; Vasquez et al., 1994), and careful combi-
nation of brain tubulin, XKCM1, and XMAP215 can reca-
pitulate nearly physiological levels of all four parameters of
dynamic instability (Kinoshita et al., 2001). Together, these
in vivo and in vitro data have led to the model that members
of the Dis1/XMAP215 family are important factors regulat-
ing physiological MT dynamics in all cells by promoting po-
lymerization.
In light of our results, it will be interesting to investigate
more closely whether Dis1/XMAP215 family members
might also play a role in MT depolymerization in the cell.
Consistent with this, recent work by van Breugel et al.
(2003) demonstrates that the 
 
S
 
. 
 
cerevisiae
 
 homologue (Stu2)
does not promote MT growth in vitro but instead slows po-
lymerization and promotes catastrophes. There are at least
two places where Dis1/XMAP215 family members are can-
didates for site-specific depolymerizing activity. First, in fis-
sion yeast, both homologues (Dis1 and Alp14) localize to ki-
netochores, which are sites for plus end depolymerization (as
well as polymerization) during chromosome oscillation and
segregation (Garcia et al., 2001; Nakaseko et al., 2001).
Tantalizingly, recent evidence in that system points to a syn-
ergistic, not antagonistic, relationship between Dis1/Alp14
and the KinI-like kinesins klp5/6 at the kinetochore (Garcia
et al., 2002). Second, in every system examined to date,
Dis1/XMAP215 localizes tightly to centrosomes and mitotic
spindle poles (Ohkura et al., 2001). An MT-depolymerizing
factor that localizes to spindle poles would be an attractive
candidate for the minus end–depolymerizing activity associ-
ated with poleward MT flux. The tiny spindles that result
from XMAP215 depletion in frog extract have not been
tested for their flux rates. However, at least in vitro,
XMAP215 depolymerization appears to be specific to MT
plus ends. It is possible that XMAP215 acts as an MT poly-
merizer at centrosomes and an MT depolymerizer at kineto-
chores. Or, it is possible that XMAP215 at centrosomes de-
polymerizes MTs that are misoriented with their minus ends
Figure 6. Mechanism of CPP MT depolymerization by XMAP215. 
(A) Nocodazole does not depolymerize CPP MTs in our assay. 
Dimer sequestration was tested by incubating rhodamine-labeled 
CPP MTs with buffer plus DMSO or 20  M nocodazole. (B) XMAP215 
does not accelerate hydrolysis of GMPCPP. TLC was used to detect 
the hydrolysis of  -
32P–labeled GMPCPP in CPP MTs treated with 
buffer alone, full-length XMAP215, NH2-terminal fragment of 
XMAP215, or Na-BRB80/60% glycerol (positive control). Time 
points were taken from each reaction at 0, 30, and 60 min. 
[ -
32P]GMPCPP (CPP), [ -
32P]ATP (ATP), and 
32Pi (Pi) are loaded 
as markers. Release of Pi is seen by the appearance of a second spot 
in Na-BRB80/60% glycerol, but not in XMAP215 or NH2-terminal 
XMAP215 samples. Microscopy assays run in parallel demonstrated 
that treatment with XMAP215 and the NH2-terminal construct 
depolymerized CPP MTs by the final time point (not depicted). 
(C) XMAP215 causes protofilament curling on MT ends. CPP MTs 
were incubated in buffer alone or buffer plus 38.5 nM full-length 
XMAP215 for 2 min and imaged by negative stain EM. Bars: (left) 
200 nm; (right) 50 nm.T
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out or, at spindle poles, depolymerizes spurious plus ends
from the opposite pole. Interestingly, the major phenotype
of decreasing ch-TOG levels in HeLa cells by RNAi is not
MT destabilization (as would be expected for an MT stabi-
lizer) but spindle MT disorganization (Gergely et al., 2003).
Further investigation will be necessary to determine if
XMAP215 ever functions in vivo as an overt depolymerizer.
Mechanistic implications for XMAP215
Although most of the literature focuses on the ability of
XMAP215 to promote polymerization, our observation that
XMAP215 can destabilize MTs is not without precedent.
Vasquez et al. (1994) had previously shown that purified
XMAP215 increased the MT depolymerization rate as well
as polymerization rate, and that it inhibits rescue events.
These data are consistent with lattice-destabilizing activity,
as are the data of van Breugel et al. (2003) for Stu2.
Because full-length XMAP215 had depolymerizing activ-
ity in our in vitro assay, proteolysis cannot account for con-
version of a polymerizing factor into a depolymerizing fac-
tor. Both polymerizing activity (Popov et al., 2001) and
depolymerizing activity map roughly to the NH2-terminal
1/4 of XMAP215. More precise mapping might separate
these functions in the future. However, given that both ac-
tivities act primarily on MT plus ends, our current working
model is that XMAP215’s polymerization-promoting and
CPP MT–destabilizing activities are two aspects of a com-
mon biochemical mechanism.
What might this common mechanism be? Our prelimi-
nary studies suggest a model in which XMAP215 alters the
conformation of the MT end to promote depolymerization,
possibly by affecting interactions between protofilaments.
The mechanism by which XMAP215 promotes polymeriza-
tion specifically on the MT plus end is not known. Two
hypotheses have been considered (Spittle et al., 2000):
XMAP215 might oligomerize tubulin dimers in solution
and thus catalyze addition of several dimers per association
event; alternatively, it might alter the structure of the grow-
ing end, promoting a structure that either adds dimers more
rapidly or is less likely to undergo brief pause events. The
latter model, in which Dis1/XMAP215 modifies the end of
the MT lattice so as to promote dynamicity, potentially al-
lows a unified explanation for all four activities of the pro-
tein (promoting polymerization, promoting depolymeriza-
tion, antagonizing/inhibiting rescue, and depolymerizing
CPP MTs). A key clue might come from the specialized,
nonphysiological CPP MT substrate and in understanding
what physiological state it mimics most closely.
The CPP lattice has most often been used as a model for
the GTP cap (Drechsel and Kirschner, 1994; Caplow and
Shanks, 1996). However, the blunt-ended, closed tube struc-
ture of the CPP MT lattice is not similar to the sheet-like
end of a growing MT, nor does it resemble the rams’ horns
of a shrinking MT (Simon and Salmon, 1990; Mandelkow
et al., 1991; Chretien et al., 1995). We propose instead that
CPP MTs are a model for the MT pause state. Tran et al.
(1997) proposed a three-state model for dynamic instability
in which the pause state is an obligate intermediate between
polymerization and depolymerization. Neither the structure
nor the bound nucleotide of the hypothetical pause state is
known. It seems reasonable to suggest that the pause state
might have a blunt-ended, closed tube structure, intermedi-
ate between the sheet-like protofilament extensions and
curled protofilaments characteristic of growth and shrinkage.
Consistent with this idea, Chretien et al. (1995) proposed
that loss of sheet-like protofilament extensions correlated
with slower growth. A plus end that paused long enough
would presumably exchange nucleotide at the exposed
E-sites (Mitchison, 1993), resulting in GTP-bound tubulin
subunits at the tip of a paused plus end. The exposed end of
a CPP MT that is blunt and contains a GTP analogue may
mimic this hypothetical blunt, exchanged state of an MT in
which all the internal subunits are GDP bound.
This interpretation of what the CPP lattice mimics
prompts us to propose that XMAP215 destabilizes the pause
state, acting as an antipause factor (Fig. 7). MTs frequently
pause in vivo, spending prolonged time neither growing nor
shrinking at the resolution level of the light microscope
(Shelden and Wadsworth, 1993; Tirnauer et al., 1999; Ru-
san et al., 2001). MTs also pause during phases of polymer-
ization and depolymerization in Xenopus extracts (Tirnauer
et al., 2002). Pauses are infrequent in reports of pure tubulin
dynamics (Walker et al., 1988), but it is possible that pure
MTs undergo micropauses too short to be detected by con-
ventional imaging. In this pause state, MTs can theoretically
transition into either growth or shrinkage, and a factor that
destabilizes the pause state would increase MT dynamicity.
Whether the MT transits to growth or shrinkage may de-
pend on its environmental cues (tubulin concentration,
other proteins, nucleotides, salt, or buffer); this would ex-
Figure 7. Model for the potential mechanism of XMAP215 as an 
antipause factor. Depicted here are the growing MT end (top) as a 
sheet-like structure of protofilament extensions and the shrinking 
MT end (bottom) with curled protofilaments (adapted from Miyamoto 
et al., 2002). The hypothetical paused MT end structure (middle) is 
positioned as an obligate intermediate between the two, drawn here 
with a blunt-ended, closed tube structure. We propose that XMAP215 
destabilizes this pause state by weakening interprotofilament bonds 
and/or preventing tube closure, increasing transition to either the 
growing or shrinking state (arrows). Based on work by Cassimeris et 
al. (2001), we depict XMAP215 here as a long curved molecule that 
can bind protofilaments along their long axis.T
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plain the apparently contradictory behavior of XMAP215 in
different contexts. An antipause factor would also increase
both apparent polymerization and depolymerization rates if
polymerization and depolymerization were rate limited by
micropauses. Higher resolution tracking of growing ends
with pure tubulin could test this assumption. The antipause
hypothesis could also account for the plus end specificity of
XMAP215 if, for example, micropauses, corresponding to
loss of protofilament extensions (Chretien et al., 1995),
limit plus end growth and shrinkage more than minus end
growth and shrinkage. Indeed, the pause model was intro-
duced to account for different stabilities of the plus and mi-
nus ends (Tran et al., 1997).
MT depolymerization is necessary for every aspect of mi-
totic spindle function, from the breakdown of MTs in
prophase to the search and capture of kinetochores to kine-
tochore oscillations, flux, anaphase movement, and spindle
disassembly after anaphase. The in vivo function of Dis1/
XMAP215, currently thought of as an MT growth–promot-
ing factor, should be reexamined to look for functions that
might depend on its MT-destabilizing activity, an equally
important aspect of its biochemistry. Interesting areas of fu-
ture research include determining whether the two appar-
ently opposed activities of XMAP215 are separable, either
biochemically or by mutation, and asking if XMAP215 ex-
hibits these two activities because it is, fundamentally, an an-
tipause factor. Addressing these questions should inform us
as to the molecular mechanisms underlying physiological
MT dynamics.
Materials and methods
Xenopus egg extracts
CSF-arrested extracts and in vitro spindle assembly reactions were pre-
pared as previously described (Desai et al., 1999a). For large-scale purifi-
cation, the following adjustments were made. Packing and crushing spins
were performed in 50-ml (28.7   103.3 mm) tubes (Nalgene; Nunc), with
25–30 ml of eggs per tube. The packing spin consisted of 1 min at 500 rpm
and 30 s at 1 krpm in a clinical centrifuge (Sorvall); the crushing spin was
performed at 12.5 krpm ( 21,000 g) for 15 min at 16 C in a Surespin 630
rotor (Sorvall). Crude CSF extract was then clarified at 4 C either in a TH-
641 rotor (Sorvall) for 4 h at 41 krpm ( 200,000 g) or in two AH650 rotors
(Sorvall) for 2 h at 50 krpm ( 235,000 g). Typically, 20–25 ml of clarified
CSF extract ( 40 mg/ml protein) was obtained from 1 liter of eggs (pre-
dejellying volume). Clarified extract was supplemented with cyto D (10
 g/ml final; Sigma-Aldrich), protease inhibitors (10  g/ml final each, leu-
peptin, pepstatin A, chymostatin; Sigma-Aldrich), and energy mix (7.5 mM
creatine phosphate, 1 mM ATP, 1 MgCl2 final) before being flash frozen in
liquid nitrogen in 1-ml aliquots.
In vitro assay for CPP MT depolymerization
Tubulin was labeled with tetramethyl- or X-rhodamine (Molecular Probes)
as previously described (Hyman, 1991) and was used to prepare CPP MTs
using standard procedures (Hyman et al., 1992; Caplow et al., 1994). Con-
centration of tubulin (1:3, labeled/unlabeled) during polymerization was
0.4 mg/ml (4  M), and GMPCPP concentration was 200  M. After poly-
merization at 37 C for 30 min, MTs were removed from the water bath and
placed to cool at room temperature for 5–15 min. For each reaction, 0.5  l
of polymerized CPP MTs was added to 10  l of buffer or buffer plus sam-
ple, for a final tubulin concentration of 200 nM. Reactions were staggered
for fixed time points. 1  l of each reaction was fixed with 2  l of 80% glyc-
erol/0.1% glutaraldehyde after 10 or 15 min incubation. During the purifi-
cation, column fractions were assayed after  10-fold dilution in assay
buffer (50 mM  -glycerol phosphate, pH 6.8, 50 mM sucrose, 5 mM EGTA,
1 mM DTT). When necessary, 100  l of each fraction was desalted using
1-ml disposable spin columns filled with equilibrated G-25 fine resin. De-
salting of samples with low protein concentration led to high loss of activity
unless detergent was added (0.5% CHAPS) or protein concentration supple-
mented to 0.5 mg/ml with purified ovalbumin (Sigma-Aldrich).
For quantitative measurement of activity with pure XMAP215 con-
structs, the following adjustments were made. Assays were performed in
extract buffer (CSF-XB, 100 mM KCl, 50 mM sucrose, 10 mM K-Hepes, pH
7.7, 5 mM EGTA, 2 mM MgCl2, 0.1 mM CaCl2). After 15 min, 3  l of each
reaction was mixed thoroughly with 3  l of fix. 2  l of this mixture was
squashed under a coverslip for a thin homogenous sample. Images ( 50
random fields per sample) were acquired on an upright Nikon E-600 or
E-800 microscope equipped with a cooled charge-coupled device camera
(Princeton Instruments) using MetaMorph software (Universal Imaging
Corp.). Images for each sample were made into a stack and thresholded
using an average background value for that set (which was always much
lower than the intensity of MT fluorescence). Integrated Morphometry
Analysis was used to count the number of objects (MTs) per field, the
length of each object, and the fluorescent pixel area of each object. Results
were logged and analyzed in Microsoft Excel 2000. Average MT length
can be skewed by a few long MTs in the field (versus many MTs of varied
length) and average MT number per field by a large number of very small
MTs. We felt that fluorescent pixel area values best represent total MT
polymer as these measurements incorporate both length and number.
Other parameters (such as average length   number or the average sum of
MT lengths per field) would take into account both length and number but
assume that all MTs are the same width; unfortunately, some fields (such
as samples with high concentrations of full-length XMAP215) contained
bundled MTs that were considerably wider than the average MT. Also, flu-
orescent pixel area was an easier parameter to quantitate for multiple fields
using automated image morphology analysis. Recombinant full-length
XMAP215 and truncated proteins tested in the in vitro CPP MT depolymer-
ization assay were gifts from K. Kinoshita, D. Drechsel, and A. Hyman
(Max Planck Institute, Dresden, Germany).
Determination of sedimentation value
50  l of clarified extract or 10–20  l of purified fraction (sup6 or monoS2)
was sedimented through a 5-ml linear 5–20% sucrose gradient in assay
buffer or CSF-XB (both buffers contain 50 mM sucrose on top of additional
sucrose) for 5–14 h at 50 krpm in an SW50 (Beckman-Coulter) or AH650
(Sorvall) rotor. 250- l fractions were collected from top to bottom. 20  l of
protein standard solution was run on two parallel gradients. Protein stan-
dard solution consisted of ovalbumin (3.55S), bovine serum albumin
(4.3S), aldolase (7.3S), and catalase (11.3S).
Purification of XMAP215 as a CPP MT–depolymerizing factor
20 ml of Xenopus high-speed supernatant was thawed, pooled, and split
into two 15-ml snap-cap tubes. After addition of supplemental energy mix
and creatine kinase (50  g/ml final; Sigma-Aldrich), the extract was spun
in a Sorvall SA-600 rotor for 15 min at 10 krpm, 4 C. The supernatant was
recovered, and 0.226 g of finely ground AS powder was added per millili-
ter, slowly and with continuous stirring, for a final concentration of 40%
AS. Extract was rotated in the cold room for 1 h and spun for 10 min at 10
krpm in the SA-600 rotor, 4 C. Supernatant was collected and diluted
fivefold into PS buffer (40% AS, 50 mM  -glycerol phosphate, 50 mM su-
crose, 5 mM EGTA, 1 mM DTT).  -Glycerol phosphate served as both
buffer and phosphatase inhibitor, being useful for maintaining proteins in
mitotic state during purification from Xenopus egg extract (Takada et al.,
2000). Diluted supernatant (AS supe) was syringe filtered through a 0.45-
 m membrane and loaded slowly (1 ml/min) with a Gilson pump directly
onto an  30-ml XK 26/16 phenyl sepharose column (Amersham Bio-
sciences). A 300-ml reverse gradient of 40–0% AS was applied to the col-
umn at 3 ml/min, and 10-ml fractions were collected. Activity eluted be-
tween 24 and 17% AS.
After desalting over a 50-ml HiPrep 26/10 desalting column (Amersham
Biosciences) equilibrated in MS buffer (20 mM MOPS, pH 7.0, 50 mM
 -glycerol phosphate, 50 mM sucrose, 5 mM EGTA, 1 mM DTT), protein
(PS pool) was loaded onto a 5-ml Hi-Trap heparin column (Amersham Bio-
sciences) and eluted with a linear 50-ml gradient up to 0.5 M KCl. Activity
eluted at  250 mM KCl. Active fractions were pooled (hep pool), supple-
mented with 0.5 mg/ml ovalbumin or human serum albumin final, con-
centrated via preblocked microcons, and rediluted until conductivity as-
says showed that total salt had been reduced to 0.35 mS. Pooled fractions
were loaded on a 1-ml MonoS column (Amersham Biosciences) at 0.5 ml/
min or, alternatively, on a 100- l SMART system MonoS column (Amer-
sham Biosciences) with repeated cycles of loading and elution. In both
cases,  90% of the protein flowed through. Bound protein was eluted
with a linear gradient of 0–500 mM KCl in MS buffer and activity eluted at
160 mM KCl.T
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These fractions were pooled (monoS1), concentrated via microcon to a
final volume of 100  l, refiltered through a 0.22- m spin filter, and ap-
plied to a 1-ml SMART system Superose 6 column (Amersham Bio-
sciences) that had been previously equilibrated with assay buffer. Activity
eluted at  1.45 ml. Four or five fractions of 50  l each were pooled
(sup6), diluted into MQ buffer (180 mM KCl, 20 mM Tris-HCl, pH 6.0, 50
mM sucrose, 5 mM EGTA, 5 mM MgCl2), and loaded on a 100- l SMART
system MonoQ column (Amersham Biosciences). Activity appeared in the
flowthrough (Q FT), which was supplemented with MOPS to pH 7.0 and
diluted to a final KCl concentration of 50 mM. The Q FT was applied to a
100- l SMART system MonoS column (Amersham Biosciences). During a
linear gradient of 0–500 mM KCl, a single peak of activity again eluted at
160 mM KCl. 50- l fractions (monoS2) were collected and assayed. Frac-
tions were pooled and sedimented on a 2-ml 5–20% sucrose gradient
(TLS-55 rotor, 50 krpm, 4 h, 4 C) or run on SDS-PAGE for silver stain.
Purification was complicated by nonspecific losses in activity when
protein concentration was too low. For this reason, in the last two or three
steps, protein levels were supplemented to 0.5 mg/ml during column load-
ing with purified ovalbumin, which binds monoQ and flows through
monoS in our MQ and MS buffers, respectively. As losses in activity were
also incurred by freeze–thaw, the purification protocol was performed
over several days at 4 C, without freezing any active fractions.
Mass spectrometry
MonoS final fractions were separated on an 8% polyacrylamide gel by
SDS-PAGE. The gel was silver stained with the following protocol: 10 min
in 50% methanol; 10 min in 5% methanol; 10 min in 250 ml H2O contain-
ing 8  l of 1 M DTT; 10 min in silver solution (0.2% AgNO3); brief wash
with milliQ water (3   10 s); brief wash with a small amount of develop-
ing solution (7.5 g of Na2CO3 in 250 ml water plus 125  l 37% formalde-
hyde); brief wash with a small amount of milliQ water; addition of the re-
maining developing solution until bands are of desired intensity; quench
by pouring off developing solution and adding 5% AcOH; 3   15 min
washes with water. After silver stain, p130 bands were carefully excised
and subjected to tryptic digest before liquid chromatography tandem mass
spectrometry and database analysis; these procedures were performed at
Taplin Biological Mass Spectrometry Facility at Harvard Medical School.
Immmunoreagents
Antibodies specific to the NH2-terminal 560 aa of ch-TOG and antibodies
specific to the COOH-terminal 15 aa of ch-TOG were a gift from K. Kino-
shita and A. Hyman. Anti-katanin antibody was a gift from F. McNally (Uni-
versity of California, Davis, CA). Inhibitory XKCM1 antibodies were pro-
vided by both C. Walczak (University of Indiana, Bloomington, IN) and R.
Ohi (Harvard University) inhibitory activity was confirmed both in extract
(Fig. 3 D) and in in vitro assays with recombinant XKCM1 (not depicted).
Immunodepletion of Xenopus egg extracts was performed with Dynabeads
as previously described (Tournebize et al., 2000). Efficient depletion of
XMAP215 was achieved using a polyclonal rabbit antibody raised against
the last 16 aa at the COOH terminus after two rounds of depletion, using
12.5  g of antibody per 50  l of beads per round for 140  l of crude ex-
tract. Similar concentrations of rabbit IgG (Sigma-Aldrich) and anti-XKCM1
antibody were used for each round of mock and XKCM1 depletions.
Time-lapse microscopy and flow cell assay
Flow cells were constructed using GoldSeal glass slides, 18   18-mm
square GoldSeal coverslips, and thin strips of double-sided Scotch tape.
Each coverslip was rinsed in acetone for 10–15 min before being spun dry
and then air dried on Whatman paper (15–30 min). Coverslips were in-
verted onto two pieces of double-sided tape stuck to a glass slide, creating
chambers of  10–15  l. Reagents were pipetted into one end and drawn
out the other with triangles of whatman paper in this order: (1) 1 vol of 100
 g/ml kinesin (gift from Z. Maliga, Harvard University) in 20 mM Tris-HCl,
pH 7.0, 1 mM DTT, incubated 10 min; (2) 5–8 vol of 6.5 mg/ml casein, in-
cubated 10 min; (3) 5–8 vol BRB80   1 mM DTT; (4) 3–5 vol of CPP MTs,
usually diluted to 400 nM, incubated 10 min; (5) 5–8 vol BRB80   1  ox-
ygen scavenging mix (OS, 4.5 mg/ml glucose, 0.035 mg/ml catalase, 0.2
mg/ml glucose oxidase, 0.5%  -mercaptoethanol in CSF-XB); (6) 5–8 vol
CSF-XB   OS; (7) 3–5 vol CSF-XB   OS   19 nM XMAP215 (full-length
recombinant protein)   10  M MgATP. Though kinesin motility was fast
and reliable in BRB80, CPP MTs were often released by kinesin in CSF-
XB   ATP, necessitating high concentrations of kinesin in step 1 and low ATP
concentrations in step 7. Dim-bright CPP MTs were made as previously
described (Hyman, 1991), polymerizing 0.4 mg/ml of 1:1 (labeled/unla-
beled) tubulin plus 200  M CPP for bright seeds and using 36  g/ml of
these seeds in  0.2 mg/ml of 1:7 (labeled/unlabeled) tubulin for dim MT
elongation. Time-lapse movies were made by taking 100-ms exposures
(bin   2) every 5–15 s, using microscopy equipment as described above.
Movies were analyzed using Metamorph as follows: movies were recorded
as stacks; planes corresponding to two time points were duplicated from
the stack; using color combine, the two planes were overlaid in two differ-
ent colors; using the line region tool, MT lengths were measured on either
side of a fiduciary mark; polarity could be assigned by comparing the loca-
tion of the fiduciary mark in each plane. We only used MTs with clearly
distinguishable ends in both planes and clear movement of the fiduciary
mark. MT length measurements were logged to a spreadsheet in Microsoft
Excel for further analysis.
GMPCPP hydrolysis
[ -
32P]GMPCPP was synthesized from GMPCP and [  -
32P]ATP. 2 U of nu-
cleotide diphosphate kinase (Sigma-Aldrich), 15  l of 1 mM GMPCP in
BRB80, and 15  l of [ -
32P]ATP were incubated at room temperature for
6 h. The reaction was spun for 15 min in a microfuge, and the supernatant
was filtered through a 10K cut-off filter. 0.1  l of each reaction product
was analyzed by TLC using PEI-cellulose plates (Baker-Flex) run in 1.0 M
LiCl and detected using a phosphorimager (Molecular Imager FX; Bio-Rad
Laboratories) and Quantity One v.4.1.1 software. Standards (1  l each of
10 mM GMPCPP, ATP stocks) were run in parallel and detected using a
handheld UV lamp.
[ -
32P]GMPCPP was used to monitor phosphate hydrolysis in the depoly-
merization reaction. Depolymerization reactions were performed as de-
scribed above, using 75 nM full-length, recombinant XMAP215 or NH2-ter-
minal fragment, except that 15  l of [ -
32P]GMPCPP was added during CPP
MT polymerization to incorporate it into the lattice. Reactions without [ -
32P]GMPCPP were performed in parallel, to monitor the extent of depoly-
merization by visual assay. Phosphate hydrolysis was monitored by taking
6.7  l of each reaction at 0, 10, and 20 min for assays in assay buffer and at
0, 30, and 60 min for assays performed in BRB80 or BRB80   5 mM EDTA.
Results were equivalent for each buffer condition. Time points were
quenched by addition of an equal volume of denaturing buffer (8 M urea, 20
mM Tris-HCl, pH 7.0, 5 mM EDTA). As a positive control, depolymerization
reactions were performed in 60% glycerol/Na-BRB80, which is known to in-
duce hydrolysis of GMPCPP. Free 
32Pi was separated from [ -
32P]GMPCPP
by TLC on PEI-cellulose using 0.75 M sodium phosphate, pH 4.2, after first
prerunning (postload) each TLC plate with ddH2O to get rid of excess salt,
urea, and glycerol. Radioactive reaction products were detected using a Mo-
lecular Imager FX phosphorimager and Quantity One v.4.1.1 software.
Negative stain EM
Negative stain EM was performed as previously described (Desai et al.,
1999b). Standard depolymerization reactions were performed, using 38.5
nM XMAP215, except that each sample was spun for 15 min on high at
4 C in a microfuge before addition of rhodamine-labeled CPP MTs, and re-
actions were performed in BRB80 buffer.
Online supplemental material
The supplemental material (Figs. S1 and S2; Video 1) is available at http://
www.jcb.org/cgi/content/full/jcb.200211095/DC1. Fig. S1 shows repre-
sentative fluorescent images of spindles made in extracts depleted with
control (IgG),  XKCM1, or  XMAP215 antibodies. Fig. S2 is a Coomassie-
stained gel of the three XMAP215 constructs used in in vitro depolymeriza-
tion assays. Video 1 is a time-lapse video of dim-bright microtubules
treated first with buffer alone and then with buffer plus 19  M XMAP215.
The microtubules are being translocated with their minus ends leading.
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